Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-23T18:19:57.657Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevention of Mania and Maintenance Treatment in Bipolar Disorder

Published online by Cambridge University Press:  07 November 2014

Charles L. Bowden
Get access Rights & Permissions [Opens in a new window]

Extract

Prevention of mania and maintenance treatment in bipolar disorder is largely routed in the decision to use monotherapy or combination therapy in the treatment regimen. The ability to weigh efficacy against adverse effects is of particular importance in maintenance of this disorder, as most bipolar patients require lifelong use of medication. This discussion will focus on the above mentioned topics, using a case presentation as an example.

Type
Research Article
Information
CNS Spectrums , Volume 14 , Issue S15: Practical Management Strategies for Acute Mania and Mixed Episodes of Bipolar Disorder , December 2009 , pp. 12 - 15
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Tohen, M, Bowden, C, Smulevich, AB et al. , Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry. 2008;192:135–143.CrossRefGoogle ScholarPubMed
2.Bowden, CL, Calabrese, JR, McElroy, SL et al. , A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry. 2000;57:481–489.CrossRefGoogle ScholarPubMed
3.McElroy, SL, Bowden, CL, Collins, MA et al. , Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. J Affect Disord. 2008;107(1–3):127–133.CrossRefGoogle ScholarPubMed
4.Frangou, S, Donaldson, S, Hadjulis, M, Landau, S, Goldstein, LH. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry. 2005;58:859–864.CrossRefGoogle ScholarPubMed
5.Altshuler, LL, Ventura, J, van Gorp, WG, Green, MF, Theberge, DC, Mintz, J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry. 2004;56:560–569.CrossRefGoogle ScholarPubMed
6.Bowden, CL, Collins, MA, McElroy, SL et al. , Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology. 2005;30:1932–1939.CrossRefGoogle ScholarPubMed
7.Feske, U, Frank, E, Mallinger, AG et al. , Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000;157:956–962.CrossRefGoogle Scholar
8.Thompson, , et al. Psychiatry Res. 2009. In pressGoogle Scholar
9.Goldberg, JF, Perlis, RH, Bowden, CL. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009;166:173–181.CrossRefGoogle ScholarPubMed